HomePRLD • NASDAQ
add
Prelude Therapeutics Inc
Previous close
$0.64
Day range
$0.64 - $0.71
Year range
$0.61 - $6.80
Market cap
39.17M USD
Avg Volume
234.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 4.00M | — |
Operating expense | 37.83M | 1.21% |
Net income | -28.73M | 13.13% |
Net profit margin | -718.27 | — |
Earnings per share | -0.37 | 17.78% |
EBITDA | -33.34M | 10.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 133.61M | -42.64% |
Total assets | 175.52M | -36.79% |
Total liabilities | 44.06M | 8.58% |
Total equity | 131.46M | — |
Shares outstanding | 55.15M | — |
Price to book | 0.27 | — |
Return on assets | -45.38% | — |
Return on capital | -52.20% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -28.73M | 13.13% |
Cash from operations | -20.74M | 12.02% |
Cash from investing | 22.12M | 185.91% |
Cash from financing | -34.00K | -100.13% |
Net change in cash | 1.34M | -85.74% |
Free cash flow | -13.01M | -3.59% |
About
Founded
2016
Headquarters
Website
Employees
131
